| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-resistant) |
- |
- |
4 － 128 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
434 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-resistant) |
- |
- |
6.25 － >100 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
17 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
0.5 |
1 |
≤0.06 － 2 |
Moxifloxacin (BAY 12-8039, Avelox) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
0.5 |
1 |
≤0.06 － 2 |
Trovafloxacin (Trovan) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
0.5 |
4 |
≤0.06 － 8 |
Sparfloxacin (AT-4140, Zagam) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
1 |
2 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
1 |
4 |
≤0.06 － 8 |
Trovafloxacin (Trovan) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
2 |
2 |
≤0.06 － 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
2 |
8 |
0.12 － 16 |
Levofloxacin (Levaquin, Quixin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
4 |
16 |
≤0.06 － 64 |
Sparfloxacin (AT-4140, Zagam) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
4 |
16 |
1 － 64 |
Levofloxacin (Levaquin, Quixin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
8 |
16 |
1 － 32 |
Ofloxacin (Floxin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
16 |
32 |
≤0.06 － 32 |
Grepafloxacin (Raxar) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
16 |
32 |
≤0.06 － 64 |
Grepafloxacin (Raxar) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
16 |
32 |
1 － 64 |
Ofloxacin (Floxin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
64 |
256 |
≤0.06 － >256 |
Gentamicin (Gentamycin, Garamycin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant + methicillin-susceptible) |
>64 |
>256 |
0.25 － >256 |
Gentamicin (Gentamycin, Garamycin) |
21 |
| Staphylococcus aureus (ciprofloxacin-resistant) |
- |
- |
≥4 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
452 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.015 |
0.12 |
0.015 － 0.25 |
Besifloxacin (Besivance) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.025 |
0.025 |
0.0125 － 0.05 |
Garenoxacin (T-3811, BMS-284756) |
17 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
0.06 |
0.015 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
0.12 |
0.03 － 0.12 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.05 |
0.05 |
0.0125 － 0.1 |
Trovafloxacin (Trovan) |
17 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 0.12 |
Grepafloxacin (Raxar) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 0.12 |
Moxifloxacin (BAY 12-8039, Avelox) |
21 |